A citation-based method for searching scientific literature

Maria D Lozano, José I Echeveste, Marta Abengozar, Luis D Mejías, Miguel A Idoate, Alfonso Calvo, Carlos E de Andrea. Arch Pathol Lab Med 2018
Times Cited: 30







List of co-cited articles
221 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
Jonas J Heymann, William A Bulman, David Swinarski, Carlos A Pagan, John P Crapanzano, Mehrvash Haghighi, Ladan Fazlollahi, Mark B Stoopler, Joshua R Sonett, Adrian G Sacher,[...]. Cancer Cytopathol 2017
114
30



Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.
H Wang, J Agulnik, G Kasymjanova, A Wang, P Jiménez, V Cohen, D Small, C Pepe, L Sakr, P O Fiset,[...]. Ann Oncol 2018
51
23

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
23

Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Bryce Noll, Wei-Lien Wang, Yun Gong, Jun Zhao, Neda Kalhor, Victor Prieto, Gregg Staerkel, Sinchita Roy-Chowdhuri. Cancer Cytopathol 2018
70
20

Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
Deepali Jain, Sinchita Roy-Chowdhuri. Arch Pathol Lab Med 2018
41
20

Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Lawrence J Jennings, Maria E Arcila, Christopher Corless, Suzanne Kamel-Reid, Ira M Lubin, John Pfeifer, Robyn L Temple-Smolkin, Karl V Voelkerding, Marina N Nikiforova. J Mol Diagn 2017
228
20

Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
Sinchita Roy-Chowdhuri, Hui Chen, Rajesh R Singh, Savitri Krishnamurthy, Keyur P Patel, Mark J Routbort, Jawad Manekia, Bedia A Barkoh, Hui Yao, Sharjeel Sabir,[...]. Mod Pathol 2017
67
16

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Matthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong Seok Lee, Gregory A Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak Burgers, Pamela Salman,[...]. N Engl J Med 2018
16

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
Ming Sound Tsao, Keith M Kerr, Mark Kockx, Mary-Beth Beasley, Alain C Borczuk, Johan Botling, Lukas Bubendorf, Lucian Chirieac, Gang Chen, Teh-Ying Chou,[...]. J Thorac Oncol 2018
297
16

Testing for ROS1 in non-small cell lung cancer: a review with recommendations.
Lukas Bubendorf, Reinhard Büttner, Fouad Al-Dayel, Manfred Dietel, Göran Elmberger, Keith Kerr, Fernando López-Ríos, Antonio Marchetti, Büge Öz, Patrick Pauwels,[...]. Virchows Arch 2016
110
16

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
Julien Mazières, Gérard Zalcman, Lucio Crinò, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C Dingemans, Hervé Léna, Isabelle Monnet, Sacha I Rothschild,[...]. J Clin Oncol 2015
223
16

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, D Ross Camidge, Benjamin J Solomon, Ravi Salgia, Gregory J Riely, Marileila Varella-Garcia, Geoffrey I Shapiro, Daniel B Costa,[...]. N Engl J Med 2014
16

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
Umberto Malapelle, Clara Mayo-de-Las-Casas, Miguel A Molina-Vila, Rafael Rosell, Spasenija Savic, Michel Bihl, Lukas Bubendorf, Manuel Salto-Tellez, Dario de Biase, Giovanni Tallini,[...]. Cancer Cytopathol 2017
33
16


Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
16

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.
Yasushi Yatabe, Sanja Dacic, Alain C Borczuk, Arne Warth, Prudence A Russell, Sylvie Lantuejoul, Mary Beth Beasley, Erik Thunnissen, Giuseppe Pelosi, Natasha Rekhtman,[...]. J Thorac Oncol 2019
72
16

Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality.
Annika Dejmek, Nooreldin Zendehrokh, Malgorzata Tomaszewska, Anders Edsjö. Cancer Cytopathol 2013
68
13


Cytologic-histologic correlation of programmed death-ligand 1 immunohistochemistry in lung carcinomas.
Eleanor Russell-Goldman, Sasha Kravets, Suzanne E Dahlberg, Lynette M Sholl, Marina Vivero. Cancer Cytopathol 2018
51
13

PD-L1 Expression Heterogeneity in Non-Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections.
Enrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, Luigi Marchionni, Marcella Marconi, Marco Sommaggio, Matteo Brunelli, Guido Martignoni, George J Netto, Mohammad O Hoque,[...]. J Thorac Oncol 2018
84
13

Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer.
Erik H F M van der Heijden, Roberto F Casal, Rocco Trisolini, Daniel P Steinfort, Bin Hwangbo, Takahiro Nakajima, Birgit Guldhammer-Skov, Giulio Rossi, Maurizio Ferretti, Felix F J Herth,[...]. Respiration 2014
110
13

Detection of ROS1-positive non-small cell lung cancer on cytological specimens using immunocytochemistry.
Tatjana Vlajnic, Spasenija Savic, Audrey Barascud, Betty Baschiera, Michel Bihl, Bruno Grilli, Michelle Herzog, Julien Rebetez, Lukas Bubendorf. Cancer Cytopathol 2018
18
22

ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.
Lynette M Sholl, Heather Sun, Mohit Butaney, Chengsheng Zhang, Charles Lee, Pasi A Jänne, Scott J Rodig. Am J Surg Pathol 2013
110
13

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
Joseph McLaughlin, Gang Han, Kurt A Schalper, Daniel Carvajal-Hausdorf, Vasiliki Pelekanou, Jamaal Rehman, Vamsidhar Velcheti, Roy Herbst, Patricia LoRusso, David L Rimm. JAMA Oncol 2016
465
13

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.
Christian Rolfo, Philip C Mack, Giorgio V Scagliotti, Paul Baas, Fabrice Barlesi, Trever G Bivona, Roy S Herbst, Tony S Mok, Nir Peled, Robert Pirker,[...]. J Thorac Oncol 2018
237
13

Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
Noemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, Laia Paré, Patricia Galván, Santiago Viteri, Sonia Rodríguez, Vicente Peg, Erika Aldeguer, Nuria Viñolas,[...]. Clin Chem 2017
38
13

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, Marina C Garassino, Hye R Kim, Suresh S Ramalingam, Frances A Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S M E Theelen,[...]. N Engl J Med 2017
13

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
Maria D Lozano, Javier J Zulueta, Jose I Echeveste, Alfonso Gúrpide, Luis M Seijo, Salvador Martín-Algarra, Anabel Del Barrio, Ruben Pio, Miguel Angel Idoate, Tania Labiano,[...]. Oncologist 2011
60
10

Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling.
J Keith Killian, Robert L Walker, Miia Suuriniemi, Laura Jones, Stephanie Scurci, Parvati Singh, Robert Cornelison, Shannon Harmon, Nichole Boisvert, Jack Zhu,[...]. J Mol Diagn 2010
74
10

The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma.
Bryan L Betz, Michael H Roh, Helmut C Weigelin, Jeremiah B Placido, Lindsay A Schmidt, Sara Farmen, Doug A Arenberg, Gregory P Kalemkerian, Stewart M Knoepp. Am J Clin Pathol 2011
68
10

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
Benjamin P Levy, Marc D Chioda, Dana Herndon, John W Longshore, Mohamed Mohamed, Sai-Hong Ignatius Ou, Craig Reynolds, Jaspal Singh, Ignacio I Wistuba, Paul A Bunn,[...]. Oncologist 2015
20
15


Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients.
Marius Ilie, Jonathan Juco, Lingkang Huang, Veronique Hofman, Shirin Khambata-Ford, Paul Hofman. Cancer Cytopathol 2018
57
10


Clinical evaluation of the utility of a flexible 19-gauge EBUS-TBNA needle.
Tomonari Kinoshita, Hideki Ujiie, Joerg Schwock, Kosuke Fujino, Christine McDonald, Chang Young Lee, Alexander Gregor, Chung Chun Tyan, Simon Houston, Kasia Czarnecka-Kujwa,[...]. J Thorac Dis 2018
11
27

ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.
Eugen C Minca, Christopher P Lanigan, Jordan P Reynolds, Zhen Wang, Patrick C Ma, Joseph Cicenia, Francisco A Almeida, Nathan A Pennell, Raymond R Tubbs. J Thorac Oncol 2014
39
10

Next-generation sequencing of cytologic preparations: An analysis of quality metrics.
David H Hwang, Elizabeth P Garcia, Matthew D Ducar, Edmund S Cibas, Lynette M Sholl. Cancer Cytopathol 2017
35
10


Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
Yuri E Nikiforov, Sally E Carty, Simon I Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L Ferris, William E Gooding, Shane O LeBeau, N Paul Ohori, Raja R Seethala,[...]. Thyroid 2015
210
10

Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients.
Marius Ilie, Véronique Hofman, Manfred Dietel, Jean-Charles Soria, Paul Hofman. Virchows Arch 2016
158
10


Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers.
Akihiko Yoshida, Koji Tsuta, Susumu Wakai, Yasuhito Arai, Hisao Asamura, Tatsuhiro Shibata, Koh Furuta, Takashi Kohno, Ryoji Kushima. Mod Pathol 2014
85
10

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.
Kurtis D Davies, Anh T Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L Jones, Marileila Varella-Garcia, Dara L Aisner, Robert C Doebele. J Thorac Oncol 2018
64
10


Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, Subba R Digumarthy, Daniel B Costa, Rebecca S Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott,[...]. J Clin Oncol 2009
10

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Siraj M Ali, Thomas Hensing, Alexa B Schrock, Justin Allen, Eric Sanford, Kyle Gowen, Atul Kulkarni, Jie He, James H Suh, Doron Lipson,[...]. Oncologist 2016
74
10

Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
Alexander Drilon, Lu Wang, Maria E Arcila, Sohail Balasubramanian, Joel R Greenbowe, Jeffrey S Ross, Phil Stephens, Doron Lipson, Vincent A Miller, Mark G Kris,[...]. Clin Cancer Res 2015
149
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.